Amanta Healthcare reported FY26 revenue of ₹288 crore, a 5% YoY increase, with PAT surging 42% to ₹15 crore.
EBITDA for the year stood at ₹63 crore, a 6% YoY rise, with margins improving to 22% from cost control and lower finance costs.
The company reduced its debt-to-equity ratio to 1.06x from 3.50x in FY23 and is commissioning a 10.8 MW solar plant in Q1FY27 for ₹9 crore annual savings.
Operational highlights include 96% capacity utilization, exports to 21 countries, and a 47-product portfolio across six therapeutic segments.